Challenges associated with managing medication costs include price inflation, paying for expensive brand medications, and filling non-compensable medications. Without proper management, these challenges can cause an overall rise in the cost of pharmacy expenses and a decrease in insured satisfaction. Auto no-fault insurers can gain more control over medication costs...
NAPLES, FLORIDA -- Health Management Associates, Inc. (NYSE:HMA) announced today that Page H. Vaughan has been appointed Senior Vice President and Divisional CEO for HMA's Midwest City area hospital operations, including the Oklahoma Heart Hospital South Campus joint venture. Mr. Vaughan most recently served as Senior Vice President...
Medical Institutional Services Holdings, Inc.(PINKSHEETS: MIHS) announced today the company has applied for andcompleted a name change in the state of Nevada. In addition, a new CUSIPnumber has been requested for submission to FINRA. The new company namewill be iN Control Security iCS. A symbol change has also...
10-Year-Old Boy Treated for Chronic GERD REDWOOD CITY, Calif. -- EndoGastric Solutions EGS, the recognized leader in the emerging field of Natural Orifice Surgery NOS, today announced that its innovative EsophyX([R]) device was used to complete the first ever incisionless transoral NOS surgery on a child. The 10-year-old...
AMMAN AFP — Iraq's parliament speaker Mahmud Mashhadani has been discharged from a military hospital in neighbouring Jordan after successful surgery for heart problems, a hospital official said on Monday. "Mashhadani left Al-Hussein Medical Centre on Sunday night after treatment. He was in good health," the hospital official...
ST. LOUIS, Aug. 22 /PRNewswire/ -- Barry Singer, M.D., leading neurologist and adjunct assistant professor of clinical neurology at Washington University School of Medicine, will open The MS Center for Innovations in Care on the campus of Missouri Baptist Medical Center on August 18th. (Photo: http://www.newscom.com/cgi-bin/prnh/20080822/AQF023)...
TORONTO -- A hallmark of this year's ICAD meeting was the wealth of new clinical trials information in Alzheimer's Disease AD. Years of basic and preclinical research have paved the road for development of new medications and biologics. Results from many new clinical trials were provided, ranging from promising Phase...
DALLAS, Aug. 20 /PRNewswire/ -- Digital health technologies designed to monitor and care for the elderly population will bring in U.S. revenues in excess of $1.8 billion by 2013. Technological advances will drive this growth in service and hardware revenues, according to Parks Associates' Taking Care of...
A 23-year-old Pittsburgh man who was shot while in New Orleans helping the city rebuild will return to New Orleans this weekend to attend a fundraiser at Rock 'n' Bowl to raise money for his medical expenses. Mark Smith was in New Orleans earlier this year,...
- First Product Developed from the VisEn-Merck & Co., Inc. Biomarker Imaging Program - - Expands VisEn's Leading Fluorescence Molecular Imaging Agent Portfolio and Broadens Applications in Key Areas of Disease Research and Drug Development - BEDFORD, Mass., Aug. 19 /PRNewswire/ -- VisEn Medical, Inc.,...
OMAHA, Neb. -- Most disability insurance plans cover the basics. But if you're a highly paid and specialized medical professional or attorney, how can you adequately protect your income? Mutual of Omaha has addressed this with new Long-Term Disability LTD options designed to meet the unique disability insurance needs of...
Eagles Notes Defensive end Victor Abiamiri , who is recovering from a broken right wrist, doesn't believe his season is over. "I'm trying to prepare myself by going to all the meetings and staying mentally sharp," Abiamiri said yesterday. "Things are looking good. I feel that things have gotten progressively...
Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs is pleased to announce that it has signed a term sheet with Mount Sinai Hospital to acquire a portfolio of biomarkers for use in developing diagnostic assays for the early...
WASHINGTON -- Scientists are advancing slowly toward one of the most audacious goals humans have ever set for themselves: creating artificial life. They've already accomplished some steps needed to construct a simple, single-celled organism that's capable of evolving and reproducing itself -- basic requirements for life....
BETHESDA, Md. -- Healthnostics, Inc. (PINK SHEETS: HNSO), a medical and biotechnology analytics company, is pleased to provide the following update report regarding the Company's development and progress. Trading in Healthnostics Stock The recent decrease in our stock price over the past months has occurred even...
TWINSBURG, Ohio -- Hitachi Medical Systems America Inc. HMSA today announced the first OASIS High-Field Open MRI has been installed and is available for clinical use at St. Mary Medical Center in Langhorne, Pa. The OASIS is the highlight in a multi-million dollar MRI expansion at St. Mary Imaging, which...
Beijing OLYMPICS 2008 Dave Collins, UK Athletics' performance director, said yesterday that Paula Radcliffe would only be considered for the Olympic marathon if she was fully fit. Collins was, however, optimistic that the 34-year-old would line up in Beijing on 17 August. In...
MINNEAPOLIS, Aug. 4 /PRNewswire-FirstCall/ -- ATS Medical, Inc. , manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the appointment of Craig Swandal as Vice President of Operations effective August 11, 2008. Mr. Swandal was previously the Senior Vice President of Corporate Operations for Gyrus...
DUBLIN, Ohio, Aug. 1 /PRNewswire/ -- Glomark-Governan has announced its upcoming Global CIO Value Forum 2008, an event designed to discuss best practices for measuring IT value and IT portfolio management, at the Columbus Hilton at Easton on October 2nd, 2008 in Columbus, Ohio. Keynote Speaker and...
Toronto Stock Exchange Symbol: MS EDMONTON, Aug. 1 /PRNewswire-FirstCall/ -- BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis MS, today announced that it has completed patient recruitment in its phase III clinical trial of MBP8298 dirucotide for the treatment of secondary...
Articles 2008-08-01
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors